METASTATIC TUMOR
Clinical trials for METASTATIC TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets metastatic tumors in early safety trial
Disease control OngoingThis early-phase study tests whether a new drug called AZD1390 is safe when given together with a precise type of radiation therapy (SBRT) for people whose solid tumors have spread to other parts of the body. The study involves 54 adults with metastatic cancer. The main goal is t…
Matched conditions: METASTATIC TUMOR
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New antibody TST003 takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase trial is testing a new drug called TST003 in about 111 people with advanced solid tumors (cancers that have spread or cannot be removed by surgery). TST003 is an antibody that blocks a protein called GREM1, which may help tumors grow. The main goals are to find a…
Matched conditions: METASTATIC TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC